English | Español
Amanda Rupp | Mar 11, 2016

ALS Association invests in new proposals for ALS treatment developments
Jamie Barrand | Mar 11, 2016

Opdivo under consideration in Europe for new indications
Jeff Gantt | Mar 10, 2016

TiGenix’s Cx601 trial shows positive results
Vimbai Chikomo | Mar 10, 2016

HHS estimates 43,000 have lost Obamacare tax credit after failing to file 2014 returns
Kerry Goff | Mar 10, 2016

Aetna says Hep C coverage likely to expand with new research
Jamie Barrand | Mar 9, 2016

FDA approves Imbruvica as first-line therapy for chronic lymphocytic leukemia
Jamie Barrand | Mar 9, 2016

University of Cincinnati using genetic clues from Black Plague to develop HIV therapies
Jamie Barrand | Mar 9, 2016

Possible flu therapy fast-tracked by FDA

Trending
+ Community
Patient Daily | Apr 17, 2025

ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'
+ Pharmaceuticals
Patient Daily | Apr 17, 2025

UCSF neurosurgeon: 'The idea that 340B is about helping the poor is a fiction'
+ Pharmaceuticals
Patient Daily | Apr 17, 2025

AI tool decodes cerebellar signals to improve understanding of brain disorders
+ Pharmaceuticals
Patient Daily | Apr 23, 2025

Empower Pharmacy CEO on pharmaceutical industry pricing disparities: 'Is it fair to charge one person in another country 10 times more?'